Boyle C, Cosby S L, Markey G M, Alexander H D, Morris T C
School of Biology and Biochemistry, The Queen's University of Belfast, and Department of Haematology, Belfast City Hospital, Northern Ireland.
Br J Haematol. 2000 Sep;110(3):699-703. doi: 10.1046/j.1365-2141.2000.02250.x.
Cytochemical staining of monocyte-specific esterase (MSE) is widely used for identification of the monocytic lineage in leukaemias. Deficiency of this enzymatic activity occurs as a familial trait and the deficiency has been shown to occur with greater frequency in patients with lymphoproliferative or gastrointestinal malignant neoplastic diseases than in normal blood donors. Reverse transcriptase polymerase chain reaction (RT-PCR), sequencing and quantification by Northern blot analysis was conducted on the MSE mRNA of 12 subjects with monocyte esterase deficiency (MED) and seven MSE-positive subjects to examine whether mutations were present or whether the defect was quantitative. Mutations were not found in the mRNA sequences. However, MED subjects had significantly less MSE mRNA than MSE-positive subjects (P = 0.001). These findings show that deficiency of monocyte esterase activity in MED is not as a result of the presence of inactive isoenzymes and may be owing to an abnormality in the regulation of mRNA production.
单核细胞特异性酯酶(MSE)的细胞化学染色广泛用于白血病中单核细胞系的鉴定。这种酶活性的缺乏作为一种家族性特征出现,并且已表明在淋巴增殖性或胃肠道恶性肿瘤疾病患者中比在正常献血者中更频繁地发生。对12名单核细胞酯酶缺乏症(MED)患者和7名MSE阳性患者的MSE mRNA进行逆转录聚合酶链反应(RT-PCR)、测序和Northern印迹分析定量,以检查是否存在突变或缺陷是否为定量性。在mRNA序列中未发现突变。然而,MED患者的MSE mRNA明显少于MSE阳性患者(P = 0.001)。这些发现表明,MED中单核细胞酯酶活性的缺乏不是由于无活性同工酶的存在,可能是由于mRNA产生调节异常所致。